Tag: obviousness
-
Federal Circuit Overturns PTAB Decision in Honeywell v. 3G Licensing: A Victory for Obviousness Challenges
On January 2, 2025, the Federal Circuit issued a significant ruling in Honeywell International Inc. v. 3G Licensing, S.A., reversing the Patent Trial and Appeal Board’s (PTAB) decision that upheld the validity of U.S. Patent No. 7,319,718. This ruling underscores the court’s approach to obviousness under 35 U.S.C. § 103 and highlights critical considerations in…
-
Federal Circuit Vacates PTAB Decision in Palo Alto Networks v. Centripetal Networks: Key Patent Law Takeaways
On December 16, 2024, the Federal Circuit issued an opinion in Palo Alto Networks, Inc. v. Centripetal Networks, LLC, vacating and remanding a decision by the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) proceeding. The ruling highlights critical issues in patent law, particularly regarding obviousness, motivation to combine, and the…
-
Cytiva v. JSR: Inherent Results Cannot Rescue an Otherwise Obvious Patent
In a significant decision for biotechnology and pharmaceutical patents, the Federal Circuit has affirmed-in-part and reversed-in-part the Patent Trial and Appeal Board’s (PTAB) findings in Cytiva BioProcess R&D AB v. JSR Corp.. The case centers around chromatography matrices and protein engineering, with the core dispute being whether certain patent claims were obvious and therefore unpatentable.…
-
Osseo Imaging v. Planmeca: Rejection of Temporal Limitation on Expert Qualifications
In its September 2024 decision in Osseo Imaging, LLC v. Planmeca USA Inc., the Federal Circuit reaffirmed the standard for expert qualifications in patent cases, declining to impose a temporal requirement that an expert possess ordinary skill in the art as of the time of invention. The ruling has notable implications for litigation strategy, particularly…